1. Home/
  2. Compounds/
  3. alisertib:navitoclax (2:1 mol/mol)

alisertib:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2alisertib:navitoclax (2:1 mol/mol)
PharmacoGx alisertib:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to alisertib:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZBED4 CTRPv2 pan-cancer AAC 0.28 2e-12
mRNA ADNP2 CTRPv2 pan-cancer AAC 0.23 4e-11
mRNA RCC2 CTRPv2 pan-cancer AAC 0.26 9e-11
mRNA ZNF766 CTRPv2 pan-cancer AAC 0.24 1e-10
mRNA WRN CTRPv2 pan-cancer AAC 0.24 2e-10
mRNA LDOC1L CTRPv2 pan-cancer AAC 0.24 2e-10
mRNA KLHL23 CTRPv2 pan-cancer AAC 0.24 3e-10
mRNA KCNH3 CTRPv2 pan-cancer AAC 0.22 5e-10
mRNA CBX2 CTRPv2 pan-cancer AAC 0.24 6e-10
mRNA ZNF407 CTRPv2 pan-cancer AAC 0.23 9e-10
Download CSV